Chemical hair straighteners, commonly known as hair relaxers, have long been favored by women with curly, textured hair. These products, designed to straighten and smooth natural hair, have been aggressively marketed to women of color as a means of achieving what society deems a more “desirable” hairstyle. However, recent studies have raised concerns about the […]
In an effort to streamline the litigation process for the thousands of product liability lawsuits pending against the manufacturers of chemical hair straighteners, the U.S. District Judge presiding over these lawsuits has called for the parties to submit their respective bellwether trial plans. Nearly 10,000 women across the country are currently pursuing legal claims against
Parties in Hair Straightener MDL to Submit Competing Plans for Bellwether Trials Read More »
Numerous lawsuits have been filed against cosmetic giants L’Oreal, Revlon, and other manufacturers, alleging that their hair relaxer products are associated with an increased risk of cancer and other harmful side effects. Now, a federal judge has allowed the majority of these claims to move forward, signaling a potential turning point in the ongoing legal
U.S. Judge Clears Hair Relaxer Lawsuits to Move Forward Against L’Oreal, Revlon Read More »
Chemical hair straighteners have long been a popular choice for curly-haired individuals looking to achieve sleek, straight hair. However, recent studies have raised concerns about the potential health risks associated with these products. In response, the U.S. Food and Drug Administration (FDA) has proposed a ban on certain hair-straightening and smoothing products that contain cancer-causing
FDA Proposes Ban on Hair Straightener Chemicals Linked to Cancer Risk Read More »
The U.S. Food and Drug Administration (FDA) announced this week that it is asking manufacturers of Zantac and generic ranitidine products to withdraw all prescription and over-the-counter (OTC) versions of the drug from the market immediately. The FDA’s decision is the latest step in an ongoing investigation into the presence of a carcinogenic chemical called
FDA Calls for Immediate Removal of All Zantac, Ranitidine Products from the Market Read More »
A new product liability lawsuit filed in federal court in Alabama alleges that side effects of the popular heartburn drug Zantac exposed an Alabama man to carcinogenic chemicals for years, ultimately leading to his prostate cancer diagnosis. Based on recent testing by an independent laboratory and widespread drug recalls affecting nearly every version of Zantac
Lawsuit Alleges Side Effects of Zantac Caused Prostate Cancer Diagnosis Read More »
